News
-
-
-
-
PRESS RELEASE
AndzonBio2, the ALBORADA Drug Discovery Institute at the University of Cambridge and Cambridge Enterprise Announce a Collaboration to Develop First-in-Class Therapeutics for Neuroinflammation
AndzonBio2 partners with ALBORADA Drug Discovery Institute and Cambridge Enterprise to develop innovative neuroinflammation therapeutics, targeting neurodegenerative diseases like Parkinson's and Alzheimer's -
-
PRESS RELEASE
AUSTRIACARD HOLDINGS AG and Dai Nippon Printing agree strategic framework for intended voluntary public takeover offer, irrevocable undertaking from major shareholder available
AUSTRIACARD HOLDINGS AG and Dai Nippon Printing agree strategic framework for intended voluntary public takeover offer, with irrevocable undertaking from major shareholder. Offer price at EUR 10.00 per share -
-
-
-
PRESS RELEASE
Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY
Eckert & Ziegler SE reports strong Q1 results with medical segment driving growth. Isotope Products show recovery potential. Company updates recommendation to BUY with €23 target price. For more details, visit NuWays AG's website
